doi: 10.3389/fphar.2025.1526270 Received 11 November 2024 Accepted 28 January 2025 Published 17 February 2025 Volume 16 - 2025 Edited by Alessandra Linardi, Santa Casa de So Paulo School of Medical Sciences, Brazil Reviewed by David Pubill, University of Barcelona, Spain Ariadiny Lima Caetano, Santa Casa de So Paulo School of Medical, Brazil Updates Copyright 2025 Wang, Hao, Ma, Feng, Yang, An, Su and Feng
Use of growth hormone, IGF-I, and insulin for anabolic purpose: Pharmacological basis, methods of detection, and adverse effects
The volume limit rule most protocols ignore The single most common technical error in subcutaneous injection is exceeding the volume capacity of the injection site
Potential in ED: Apart from its core uses, Rapamycin might extend lifespan and bolster cell function
AOD-9604 Oral vs Injection: Routes and Evidence AOD-9604 has been studied through more than one route, but doses cannot be directly converted between oral, intravenous, topical, nasal, and subcutaneous forms
Research suggests that it has potential benefits in enhanced muscle growth, fat reduction, improved recovery, and anti-aging